New research shows people with type 2 diabetes and chronic kidney disease who took semaglutide (commonly sold as Ozempic) once a week had improved kidney outcomes, even if they had heart disease or a ...

A systematic review and meta-analysis of nine randomized controlled trials involving 6,239 adults with overweight or obesity ...

Semaglutide is an injectable drug formulated for the treatment of type 2 diabetes, but it’s since become increasingly popular as a weight loss treatment. While the drug—commonly known by brand names ...

Digital Engagement and Predictors of Semaglutide Persis ...

A prespecified analysis of 17,604 SELECT participants found that higher baseline hsCRP was associated with greater risks of ...

Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Carley ...

Semaglutide belongs to a class of medicines known as glucagon-like peptide-1 receptor agonists, or GLP-1 RAs. Dr. Tan began by reviewing how these GLP-1 injectables work and the growing body of ...

Understand the cost benefits of generic semaglutide for Type 2 diabetes treatments compared to traditional options available ...